Keurig Dr Pepper Inc

Keurig Dr Pepper Inc

KDP

Get informed when a big investor buys or sells

+ Follow
Market Cap$41.85B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Keurig Dr Pepper IncKeurig Dr Pepper Inc22.82.99%7%2.61

Earnings Call Q1 2026

April 23, 2026 - AI Summary

Strong start to 2026; modest EPS but underlying trajectory improving - Q1 net sales +8.1% (reported): driven primarily by net price realization (+5.5 pts) and volume/mix (+2.6 pts). - Q1 EPS $0.39 (-7.1% YoY): decline attributed to cost/tariff phasing, plus a prior-year below-the-line gain lapping ($0.02). - Management tone: results “slightly ahead” of expectations, with expectations for healthier EPS growth beginning in Q2 and acceleration in the back half.
U.S. Refreshment Beverages: robust growth and profit momentum (best-performing segment) - Net sales +11.9% YoY; operating income +9.8% YoY (both double-digit). - Drivers: healthy CSD category (retail mid-single digit retail dollar growth, accelerating vs Q4), Dr Pepper share gains across regular/diet/zero, and continued DSD + distribution execution. - Innovation and growth opportunities: - Canada Dry Fruit Splash launched nationally in Feb; contributed to share gains and is expected to provide tailwinds. - Dr Pepper Creamy Coconut relaunched (dirty-sodas appeal); positioned as a major contributor through the year. - Energy/sports hydration + prebiotic/value/wellness (e.g., Bloom Pop rapid off small base; zero sugar CSDs + double-digits). - SNAP impacts: seen as manageable and consistent with expectations so far; management will monitor state-by-state waivers and adjust RGM.
U.S. Coffee: weaker near-term profit expected; headwinds easing later in year - Q1 net sales -2.3%; operating income -21.3% YoY: largely as expected. - Key negatives: - Green coffee cost pressures + tariffs (timing/flow-through to P&L), and - Trade inventory adjustments (pod shipments down ~7%, lagging POS), plus higher marketing spend. - Forecast/phasing: - Full-year U.S. Coffee expected to decline modestly in profit, with largest Q1 decline. - Improvement expected in Q2 and more meaningfully in the back half as cost inflation eases and inventory dynamics normalize. - Lower green coffee prices could be a tailwind into 2027 (manager noted “could be” supportive). - Pricing stance: 2026 pricing primarily reflects carryover from 2025 inflation offsets; management avoids committing to future price rollbacks, emphasizing consumer value and monitoring elasticity.

Exclusive for Stockcircle Pro members

Sign upSign Up
$33.20

Target Price by Analysts

7.5% upsideKeurig Dr Pepper Target Price DetailsTarget Price
$35.19

Current Fair Value

14% upside

Undervalued by 14% based on the discounted cash flow analysis.

Share Statistics

Market cap$41.85 Billion
Enterprise Value$66.66 Billion
Dividend Yield$0.92 (2.99%)
Earnings per Share$1.53
Beta0.42
Outstanding Shares1,359,200,000

Return

Return on Equity7.25%ROE
Return on Assets2.50%
Return on Invested Capital4.59%

Valuation & Multiples

P/E Ratio22.82P/E Ratio
PEG-47.77PEG
Price to Sales2.57Price to Sales
Price to Book Ratio1.47Price to Book Ratio
Enterprise Value to Revenue3.93
Enterprise Value to EBIT23.03
Enterprise Value to Net Income36
Total Debt to Enterprise0.39
Debt to Equity1.02Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
April 23, 2026
EPS Estimate
$0.37
Average shareholder expectation
Revenue Estimate
$3.84 B
Average shareholder expectation

Next Earnings Call

Expected Date
July 23, 2026
EPS Estimate
$0.55
Average shareholder expectation
Revenue Estimate
$7.25 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.8560 17.41%
Total Calls2,822,700 63.32%
Total Puts2,416,300 53.96%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %94.38% 0.88%
Total Invested$33.75B 5.09%
Investors Holding857 36.00%

ESG Score

No data

About Keurig Dr Pepper Inc

CEO: Robert Gamgort

Relevant Senate Committees

Joint Committee on Taxation

This committee's analysis and 'scoring' of tax legislation directly influence corporate tax structures, investment incentives, and the overall tax burden for companies like KDP, impacting profitability.

Finance

This powerful committee controls taxation and trade. Changes in corporate tax rates directly impact KDP's profitability, and trade policy affects ingredient sourcing costs and international market access.

Agriculture, Nutrition, and Forestry

This committee directly impacts KDP through the Farm Bill and its oversight of agricultural commodities (e.g., sugar, coffee, fruit inputs). Nutrition policy also influences consumer demand and product formulation.

Health, Education, Labor, and Pensions

This committee oversees the FDA, which directly regulates food and beverage safety, labeling, and ingredients. Labor laws also directly impact KDP's manufacturing costs and workforce management.